Alzheimer Disease

This new publication in the Advances in Alzheimer Disease Therapy Series is a comprehensive overview of the state of knowledge and practice in the development of therapies in Alzheimer disease. Clinical investigators give detailed up-to-date reports on each of the cholinesterase inhibitors that are in late stages of clinical development. Muscarinic and nicotinic agents, neuromodulators, nerve and other growth factors, are also discussed by several specialists. There is in-depth treatment of antioxidant and anti-inflammatory therapies. This volume reviews the new potential treatments and the research that promises new treatments of Alzheimer disease in the future.
This book will catch the interest of people in clinical pharmacology, neurology, psychiatry, and specialists in geriatric disease, as well as a broad range of neuroscientists and biologists interested in problems of aging, memory and the substrate of nerve degenerative diseases. This work integrates basic and clinical research findings and provides incisive evaluation of new approaches to therapy by world leaders in the field. The potential benefit for Alzheimer patients and families resulting from these research programs from molecular biology to clinical pharmacology is reviewed and evaluated.